A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites

NCT04184895 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic to House Dust Mites

Interventions

BIOLOGICAL: ASP2390
BIOLOGICAL: Placebo

Sponsor

Astellas Pharma Global Development, Inc.